Prevalence of masked hypertension and associated factors in normotensive healthcare workers

Blood Pressure Monitoring

Volumn 18, Issue 6, 2013, Pages 326-331

  Sobrino, Javier ^a   Domenech, Mónica ^b   Camafort, Miguel ^b   Vinyoles, Ernest ^c   Coca, Antonio ^b  

^a Hospital Esperit Sant   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

24 h ambulatory blood pressure monitoring; Healthcare workers; Masked hypertension

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; MALE; MASKED HYPERTENSION; NORMAL HUMAN; PREHYPERTENSION; PREVALENCE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; SMOKING; SPAIN; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MASKED HYPERTENSION; MIDDLE AGED; OBESITY; PREHYPERTENSION; PREVALENCE; RISK FACTORS; SMOKING; SPAIN;

EID: 84892400710     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000002     Document Type: Article

References (28)

1. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood pressure monitoring. Task force V: white-coat hypertension. Blood Press Monit 1999; 4:333-341.
2. Sierra C, de la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M, et al. Spanish Registry of ambulatory blood pressure monitoring: clinical characteristics of 31 530 patients. Med Clin (Barc) 2007; 129:1-5.
3. Gerin W, Schwartz AR, Schwartz JE, Pickering TG, Davidson KW, Bress J, et al. Limitations of current validation protocols for home blood pressure monitors for individual patients. Blood Press Monit 2002; 7:313-318.
4. Staessen JA, Thjis L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546.
5. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796.
6. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: A systematic review. J Hypertens 2008; 26:1715-1725.
7. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
8. Imai Y. Prognostic significance of ambulatory blood pressure. Blood Press Monit 1999; 4:249-256.
9. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249:2792-2798.
10. Pickering TG, White WB, Giles TD, Black HR, Izzo JL, Materson BJ, et al. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens 2010; 4:56-61.
11. Devereux RB, Pickering TG. Relationship between ambulatory or exercise blood pressure and left ventricular structure: prognostic implications. J Hypertens 1990; 8:S25-S34.
12. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild hypertension. Am J Cardiol 1989; 2:259-261.
13. Tsunoda S, Kawano Y, Hoio T, Okuda N, Takishita S. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002; 25:167-173.
14. Pierdomico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant and true resistant hypertension. Am J Hypertens 2005; 18:1422-1428.
15. Banegas JR, Segura J, Sobrino J, Rodriguez-Artalejo F, De la Sierra A, De la Cruz J, et al. Hypertension treatment and control. Effectiveness of blood pressure control outside the medical settings. Hypertension 2007; 49:62-68.
16. LListerri JL, Alonso FJ, Gorostidi M, Sierra C, de la Sierra A, Banegas JR, et al. Differences between control and ambulatory blood pressure in elderly. CARDIORISC-MAPARES Project. Med Clin (Barc) 2009; 133:769-776.
17. Sobrino J, Doménech M, Camafort M, Vinyoles E, Coca A. on behalf of investigators of ESTHEN group. Prevalence of masked hypertension in a cohort of controlled hypertensive patients in Spain. Med Clin (Barc) 2011; 136:607-612.
18. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
19. Mancia G, Fagard R, Narkievicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
20. National Clinical Guideline Centre. Hypertension: The clinical management of primary hypertension in adults: update of Clinical Guidelines 18 and 34 NICE Clinical Guidelines. UK: National Clinical Guideline Centre; 2011.
21. Hänninen M, Niiranen T, Puukka P, Mattila A, Jula A. Determinants of masked hypertension in the general population: The Finn-Home study. J Hypertens 2011; 29:1880-1988.
22. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E loro Associazioni (PAMELA) Study). Circulation 2001; 104:1385-1392.
23. Selenta C, Hogan BE, Linden W. How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat hypertension. Arch Fam Med 2000; 9:533-540.
24. Kim SK, Bae JH, Nah DY, Lee DW, Hwang TY, Lee KS, et al. Frequency and related factors of masked hypertension at a worksite in Korea. J Prev Med Public Health 2011; 44:131-139.
25. Schoenthaler AM, Schwartz J, Cassells A, Tobin JN, Brondolo E. Daily interpersonal conflict predicts masked hypertension in an urban sample. Am J Hypertens 2010; 23:1082-1088.
26. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. Target organ damage in 'white coat hypertension' an 'masked hypertension'. Am J Hypertens 2008; 21:393-399.
27. Shimbo D, Newman D, Schwartz E. Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: The Masked Hypertension Study. Am J Hypertens 2012; 25:664-671.
28. Maillon JM, Clerson P, Bobrie G, Genes N, Vaïse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens 2006; 24:2365-2370.